MEDIAN Technologies at the 2015 ASCO Annual Meeting
MEDIAN will exhibit its solutions for image interpretation and management in oncology trials at ASCO 2015 and will discuss the results of its abstract at Booth #22140, Hall A.
MEDIAN Technologies (ALMDT), a leading medical imaging solutions and service provider for image interpretation and management in oncology clinical trials, cancer screening programs and routine practice in oncology today announced its participation to the 2015 American Society of Clinical Oncology (ASCO) annual meeting, to be held May 29 – June 2, in Chicago, IL, USA (exhibition dates: May 30 – June 1).
During the ASCO annual meeting, the world’s premier oncology conference, MEDIAN will be at Booth #22140, Hall A to give demonstrations of our Lesion Management Solutions software – LMS- proprietary platform. MEDIAN will also present the full range of its services for image interpretation and management in clinical trials and will discuss the results of this study: Variability in data selection between local sites and blinded independent central review during a RECIST phase II trial: Association with rate of adjudication. (J Clin Oncol 33, 2015 (suppl; abstr e18555).
